OXFORD, England--(BUSINESS WIRE)--Oxford Nanopore Technologies (Oxford Nanopore) today announced the launch of a new Pharmacogenomics (PGx) Beta Program to advance personalised medicine, combining ...
Oxford Nanopore Technologies has signed a partnership with artificial intelligence developer SeqOne to support its next-generation sequencing approach in clinical diagnostic testing. The goal will be ...
OXFORD, England--(BUSINESS WIRE)--Oxford Nanopore Technologies today announced the expansion of its Compatible Products Programme (CPP), welcoming a new cohort of leading partners whose products now ...
Oxford Nanopore Technologies aims to apply its super-long-read DNA sequencing approach to new diagnostics for detecting infectious diseases, with the help of the French testmaker bioMérieux. The ...
Oxford Nanopore Technologies is looking forward to “the year of the proteome,” as co-founder and CEO Gordon Sanghera, PhD, labeled 2025 during his presentation at the recent 43rd Annual J.P. Morgan ...
A rapid, accurate way of testing for COVID-19 infection would be a big step in overcoming the virus' hold over our society. Now, in an article published in Lab on a Chip, Japanese researchers have ...
Nanopore sequencing offers comparable accuracy to short-read NGS for IGH clonotyping in CLL, with advantages in cost and laboratory footprint. The study confirms reliable somatic hypermutation status ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results